Geriatric Thoracic Surgery Ambulation Challenge
Launched by DANA-FARBER CANCER INSTITUTE · Nov 13, 2020
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Geriatric Thoracic Surgery Ambulation Challenge is a study aimed at understanding how many steps patients over the age of 65 take each day before they have thoracic surgery (surgery related to the chest area) at Brigham and Women's Hospital. The research uses a Fitbit Inspire device to track these daily steps, helping doctors learn more about the activity levels of older patients and how it might affect their surgery outcomes.
To participate in this study, you must be at least 65 years old and preparing for thoracic surgery at the hospital. However, you cannot be completely unable to walk or need help moving around without any assistance devices. Participants can expect to wear a Fitbit to measure their daily steps leading up to their surgery. This information could be valuable in improving care for older patients undergoing surgery in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients Aged ≥ 65 years
- • Who are preparing to undergo thoracic surgery at Brigham and Women's Hospital (BWH)
- Exclusion Criteria:
- • Patients who are completely non-ambulatory (i.e. wheelchair-bound-patients) \*
- • Those who lack capacity to consent due to cognitive disease.
- • Patient for which surgery is felt to be more urgent and therefore performed earlier then our required timeframe for intervention.
- • Patients with cardiac disease or angina for which formal cardiac testing is required for clearance.
- • Our exclusion criteria do not include patients with gait disturbances or those who require assistance devices for ambulation.
About Dana Farber Cancer Institute
The Dana-Farber Cancer Institute is a premier cancer research and treatment institution located in Boston, Massachusetts. Renowned for its commitment to advancing cancer care through innovative research, the institute integrates cutting-edge clinical trials with a multidisciplinary approach to patient care. With a focus on translating scientific discoveries into effective therapies, Dana-Farber collaborates with a network of leading researchers and healthcare professionals to improve outcomes for patients with cancer. The institute’s dedication to education, advocacy, and community engagement further underscores its mission to eradicate cancer and enhance the quality of life for those affected by the disease.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Boston, Massachusetts, United States
Patients applied
Trial Officials
Michael T Jaklitsch, MD
Principal Investigator
Brigham and Women's Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials